{
    "2019-12-04": [
        [
            {
                "time": "",
                "original_text": "梁锦松谈收购和和睦家：交易估值合理 对盈利很乐观",
                "features": {
                    "keywords": [
                        "梁锦松",
                        "收购",
                        "和睦家",
                        "交易估值",
                        "盈利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "健康服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "和睦家新址开业：“新东家”梁锦松、“老东家”陈启宇谈并购后合作",
                "features": {
                    "keywords": [
                        "和睦家",
                        "新址开业",
                        "梁锦松",
                        "陈启宇",
                        "并购合作"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "健康服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "四环医药昨创逾八年新低后 现逆势升近5% 连续下跌",
                "features": {
                    "keywords": [
                        "四环医药",
                        "八年新低",
                        "逆势上升",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药子公司阿莫西林胶囊过评",
                "features": {
                    "keywords": [
                        "复星医药",
                        "阿莫西林胶囊",
                        "过评"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "用研发管线抢本土创新资源！BI、AZ等之后 还有哪些MNC将入局？",
                "features": {
                    "keywords": [
                        "研发管线",
                        "本土创新",
                        "BI",
                        "AZ",
                        "MNC"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-12-03",
                "original_text": "智通港股通持股分析|12月3日",
                "features": {
                    "keywords": [
                        "智通港股通",
                        "持股分析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "港股早知道：恒指急跌急涨渐成常态 汽车板块现反弹唯趋势难以持续",
                "features": {
                    "keywords": [
                        "港股",
                        "恒指",
                        "急跌急涨",
                        "汽车板块",
                        "反弹",
                        "趋势"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "汽车",
                        "指数"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}